您当前所在位置:首页>>NRR杂志中文网>>国际审稿范例>>
      

Key gene and protein changes in the Aβ pathway following Longyanshen polysaccharide treatment in a mouse model of Alzheimer’s disease

发布者:ZhaomGJB  发布时间:2009年12月22日  点击率:
关键词:  
来源:

0000000000

Abstract

BACKGROUND: During onset and development of Alzheimer’s disease, β-amyloid precursor protein (APP), β site amyloid precursor protein cleaving enzyme (BACE), and β-amyloid (Aβ) are key genes and proteins in the β-amyloid pathway, and over-expression of these genes can lead to β-amyloid deposition in the brain.

OBJECTIVE: To observe the influence of Longyanshen polysaccharides on expression of BACE, APP, and Aβ in the senescence-accelerated prone mouse/8 (SAMP8) brain, and to compare these effects with huperzine A treatment.

DESIGN, TIME AND SETTING: A randomized, controlled, neurobiochemical experiment was performed at the Department of Pharmacology and Scientific Experimental Center of Guangxi Medical University from September 2005 to January 2008.

MATERIALS: Longyanshen polysaccharide powder was extracted from the dried slices of the medicinal plant Longyanshen. The active component, Longyanshen polysaccharide, was provided by the Department of Pharmacology, Guangxi Medical University; Huperzine A was purchased from Yuzhong Drug Manufactory, China.

METHODS: Healthy SAMP8 mice were used to establish a model of Alzheimer’s disease. A total of 50 SAMP8 mice were randomly assigned to five groups (n = 10): SAMP8, huperzine A, low-, middle-, and high-dose polysaccharide. In addition, 10 senescence-accelerated-resistant-prone (SAMR1) mice were selected as normal controls. SAMP8 and SAMR1 mice were administered 30 mL/kg normal saline; the huperzine A group was administered 0.02 mg/kg huperzine A; the low-, middle-, and high-dose polysaccharide groups were respectively administered 45, 90, and 180 mg/kg Longyanshen polysaccharides. Each group was treated by intragastric administration, once per day, for 50 consecutive days.

MAIN OUTCOME MEASURES: One hour after the final administration, immunohistochemical analysis was used to determine β-amyloid expression in the cortex and hippocampus of SAMP8 mice. Reverse-transcription polymerase chain reaction (RT-PCR) was used to determine mRNA levels of BACE and APP in SAMP8 brain tissue.

RESULTS: Compared with the SAMR1 group, Aβ expression in the cerebral cortex and hippocampus, as well as expression of BACE, APP mRNA in the brain was significantly increased in the SAMP8 group (P < 0.050.01). Compared with the SAMP8 group, Aβ expression, as well as BACE and APP mRNA expression, were significantly decreased in the cerebral cortex and hippocampus of huperzine A and low-, middle-, and high-dose polysaccharide groups (P < 0.050.01). In particular, the effect of high-dose polysaccharide was most significant (P < 0.050.01).

CONCLUSION: Longyanshen polysaccharides reduced or inhibited over-expression of BACE, APP, and Aβ in SAMP8 mice in a dose-dependent manner, and the effect was not worse than huperzine A.

Key Words: β-amyloid; beta-site amyloid precursor protein cleaving enzyme; β-amyloid precursor protein; Longyanshen polysaccharides

 


名称
大小
类型
修改日期
下载率
20090406003-2nd-ClearCopy.doc
289K
DOC
2009-12-18 15:53:17
0
20090406003-2nd-TrackedCopy.doc
292K
DOC
2009-12-18 15:53:31
0
20090406003_ClearCopyQC.doc
298.5K
DOC
2009-12-18 15:53:48
0
20090406003_TrackedCopyQC.doc
355K
DOC
2009-12-18 15:54:02
0
相似词protein;Treatment;and;long;model
评论点击

打印』『关闭

     相关链接 
更多...    
     评论 
更多...